Alcohol Septal Ablation (ASA)
ALCOHOL SEPTAL ABLATION (ASA)
Alcohol septal ablation (ASA) is a percutaneous, minimally invasive treatment performed by an interventional cardiologist to relieve symptoms and improve functional status in severely symptomatic patients with hypertrophic cardiomyopathy (HCM) who meet strict clinical, anatomic and physiologic selection criteria. In carefully selected patients, when performed by an experienced interventional cardiologist, the procedure is successful in relieving symptoms in over 90% of patients.
Hypertrophic cardiomyopathy is a condition of the heart muscle which grows abnormally thick, in the absence of a physiologic cause such as hypertension (high blood pressure) or aortic valve disease. In a large subset of patients with hypertrophic obstructive cardiomyopathy, thickening of the heart muscle in a particular part of the interventricular septum causes obstruction to blood being ejected from the left ventricle.
Alcohol septal ablation is a technique designed to reduce the obstruction to blood being ejected from the heart. The technique creates a small controlled heart attack, killing the area of heart muscle responsible for the obstruction, and eventually causing it to become less thick.
ALCOHOL SEPTAL ABLATION
Dr C. O’Mahony/Dr O. Guttmann
Equipment needed:
Barts Angiopack
6F Terumo radial sheath (RRA)
5F femoral sheath (RIJV) - if needs temporary pacing
4F temporary pacing wire
2-0 Silk suture
Tegaderm
6F EBU 3.5 guide catheter
5F JR4 diagnostic catheter
PCI kit
ChoICE floppy wire - straight tip
50mL contrast (PCI balloon solution: 50mL contrast: 50mL saline mixture)
Selection of 1.5 - 2.0 x 10mm OTW balloon
ECHO machine +/- device interrogation
Sonoview contrast
Ultrasound (Sonosite)
Sterile probe cover
Dehydrated alcohol (CD cupboard)
2mL luerlock syringe for delivery
Mild-moderate sedation (Midazolam)
Painkillers (Morphine) and anti-emetic (Metoclopramide)
*patient does NOT need antiplatelet therapy
Outcomes
Relief of obstruction is noted immediately in the majority of appropriately selected patients. Clinical success is defined as a 50% or more reduction in peak gradient across the outflow tract, predicting continued improvement in gradient and cardiac remodeling over the ensuing 1 to 2 years. Over 90% of patients experience a successful procedure, with improvement in outflow tract gradient and mitral regurgitation. Patients typically report progressive reduction in symptoms, including improved shortness of breath, lightheadedness and chest pain. Serial echocardiograms are routinely obtained to follow the cardiac remodeling over time, and document reduction in outflow tract gradient.
When compared to surgical myectomy, similar outcomes are noted out to approximately 10 years. However, a prospective, randomized trial has not been performed. Despite initial concerns regarding long-term arrhythmic potential after alcohol septal ablation, the risk appears to be no worse than for surgical myectomy. It is important to note that patients who fail to respond to alcohol septal ablation may still be candidates for surgical myectomy, and vice versa. Which patients are best served by surgical myectomy, alcohol septal ablation, or medical therapy is an important topic and one which is intensely debated in medical scientific circles.
PROCEDURAL STEPS:
RIJV access for temporary pacing (backup) (5F TPW)
RRA approach (6F)
Insert 5F JR4 diagnostic catheter to shoot RCA
Then 6F EBU 3.5 guidecatheter to engage LMS
Shoot LAD (to size septal branch)
Introduce OTW balloon with ChoICE floppy angioplasty wire
Wire the septal branch
Inflate OTW balloon in the septal branch to isolate it
Inject contrast through central lumen of OTW balloon to visulaize septal branch
Inject Sonoview contrast through central lumen and check using 2D echocardiography
if happy:
give Morphine 5mg, Metoclopramide 10mg, and appropriate sedation (Midazolam) through IV
inject dehydrated alcohol (1.5-2mL) through the central lumen of OTW balloon
shoot septal branch
re-assess hypokinesia using 2D echo
remove all system then closure of RRA using Helix or TR band
end of case